Literature DB >> 330568

Interrelations of platelet aggregation and secretion.

I F Charo, R D Feinman, T C Detwiler.   

Abstract

The mechanism of stimulus-response coupling in human platelets was investigated with a new instrument that simultaneously monitors aggregation and secretion in the same sample of plateletrich plasma. When platelets were stimulated by high concentrations of ADP, secretion began only after aggregation was almost complete. With lower concentrations of ADP or with epinephrine, biphasic aggregation was observed, and secretion began simultaneously with, or slightly after, the second phase of aggregation. When platelets were stimulated with high concentrations of gamma-thrombin or A23187, secretion and aggregation began essentially together. With very low concentrations of gamma-thrombin or A23187, biphasic aggregation was observed with secretion paralleling the second phase. At every concentration of collagen, secretion and aggregation appeared to be parallel events. Under every condition where the beginning of secretion lagged behind aggregation, secretion was dependent upon aggregation and was inhibited by indomethacin; this is referred to as aggregation-mediated platelet activation. When secretion began at the same time as aggregation, it also occurred in the absence of aggregation and was not blocked by indomethacin; this is referred to as directly induced platelet activation. These observations are consistent with a simple model of platelet stimulus-response coupling that includes two mechanisms for activation; aggregation-mediated activation is inhibited by indomethacin, while direct activation does not depend upon aggregation and is not inhibited by indomethacin. Secretion and second wave aggregation appear to be parallel events, with little evidence for second wave aggregation being a consequence of secretion as usually described.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330568      PMCID: PMC372435          DOI: 10.1172/JCI108841

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Continous monitoring of ATP-converting reactions by purified firefly luciferase.

Authors:  A Lundin; A Richardsson; A Thore
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

2.  ROLE OF ADENOSINE DIPHOSPHATE IN THE AGGREGATION OF HUMAN BLOOD-PLATELETS BY THROMBIN AND BY FATTY ACIDS.

Authors:  R J HASLAM
Journal:  Nature       Date:  1964-05-23       Impact factor: 49.962

3.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

4.  The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets.

Authors:  R D Feinman; J Lubowsky; I Charo; M P Zabinski
Journal:  J Lab Clin Med       Date:  1977-07

5.  Nucleotide and serotonin metabolism in platelets with defective secondary aggregation.

Authors:  F I Pareti; H J Day; D C Mills
Journal:  Blood       Date:  1974-12       Impact factor: 22.113

6.  Kinetics of the firefly luciferase catalyzed reactions.

Authors:  M DeLuca; W D McElroy
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

7.  Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium.

Authors:  T C Detwiler; R D Feinman
Journal:  Biochemistry       Date:  1973-06-19       Impact factor: 3.162

8.  Inhibition of platelet secretion by an antagonist of intracellular calcium.

Authors:  I F Charo; R D Feinman; T C Detwiler
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

9.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

10.  Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.

Authors:  J G White; G H Rao; J M Gerrard
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

View more
  55 in total

1.  "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.

Authors:  D T Hung; T K Vu; V I Wheaton; I F Charo; N A Nelken; N Esmon; C T Esmon; S R Coughlin
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

2.  Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.

Authors:  D T Hung; T K Vu; V I Wheaton; K Ishii; S R Coughlin
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Thrombin-induced calcium-independent degranulation of human neutrophils.

Authors:  D Baranes; J Matzner; E Razin
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

4.  Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products.

Authors:  E G Lapetina; K A Chandrabose; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

5.  Are insulin resistance and atherosclerosis the consequences of oxidative stress?

Authors:  I Wittmann; J Nagy
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

6.  Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.

Authors:  M Kurimoto; M Nishijima; Y Hirashima; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.

Authors:  M Schattner; A Parini; F Fouque; B B Vargaftig; L Touqui
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

8.  Cytotoxicity of unstimulated and thrombin-activated platelets to human tumour cells.

Authors:  T Sagawa; A Tominaga; T Kodama; M Okada
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Structure-function relationships in human alpha- and gamma-thrombins.

Authors:  L J Berliner
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 10.  Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?

Authors:  Harold J Ting; Fadi T Khasawneh
Journal:  J Biomed Sci       Date:  2010-04-06       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.